Shin Tanaka

Medicine & Life Sciences

1. Lung Transplantation 100%
2. Lung 43%
3. Tissue Donors 37%
4. Transplants 29%
5. Primary Graft Dysfunction 26%
6. Brain Death 23%
7. Cell-Free Nucleic Acids 20%
8. Living Donors 19%
9. Survival 15%
10. Lung Neoplasms 12%
11. pirfenidone 12%
12. Perfusion 12%
13. Warm Ischemia 11%
14. Heterotopic Transplantation 11%
15. Fat Embolism 11%
16. Metastasectomy 11%
17. Total Lung Capacity 10%
18. Myxoma 10%
19. Bronchiolitis Obliterans 10%
20. Coronavirus 10%
21. Neoplasm Metastasis 9%
22. Malignant Mesothelioma 9%
23. Idiopathic Pulmonary Fibrosis 9%
24. Pneumonectomy 9%
25. Replantation 9%
26. Psychology Rejection 9%
27. False Aneurysm 9%
28. Pandemics 8%
29. Airway Obstruction 8%
30. Thrombin 7%
31. Nucleic Acids 7%
32. Spain 7%
33. Sarcoma 7%
34. Survival Rate 7%
35. Hypotension 7%
36. Swine 7%
37. Glucocorticoids 7%
38. Sutures 7%
39. Methylation 7%
40. Thoracic Surgery 7%
41. Fistula 7%
42. Arm 7%
43. Hypoventilation 6%
44. Single Nucleotide Polymorphism 6%
45. Coronary Vessels 6%
46. Hypoxia 6%
47. Fats 5%
48. Lymph Nodes 5%
49. Heart Arrest 5%
50. Quality of Life 5%